Invasive Pneumococcal Disease
📧 Sign up to get email alerts when something new happens for Invasive Pneumococcal Disease.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-02-05EMA Authorised: Prevenar 13 (Pneumococcal polysaccharide serotype 1;Pneumococcal polysaccharide serotype 3;Pneumococcal polysaccharide serotype 4;Pneumococcal polysaccharide serotype 5;Pneumococcal polysaccharide serotype 6A;Pneumococcal polysaccharide serotype 6B;Pneumococcal polysaccharide serotype 7F;Pneumococcal polysaccharide serotype 9V;Pneumococcal polysaccharide serotype 14;Pneumococcal polysaccharide serotype 18C;Pneumococcal polysaccharide serotype 19A;Pneumococcal polysaccharide serotype 19F;Pneumococcal polysaccharide serotype 23F) — Pfizer Europe MA EEIG
EMA authorised Prevenar 13, a 13-valent pneumococcal conjugate vaccine, for immunization against pneumococcal infections in the EU. The vacc…
-
CLINICAL_TRIALS trial_result · 2025-10-24Clinical Trial Update: Safety Study of a Single Dose of Pneumococcal Whole-Cell Vaccine in Healthy Adults [Phase 1]
A Phase 1 safety study evaluating a single-dose pneumococcal whole-cell vaccine in healthy adults has completed, assessing safety and tolera…
-
CLINICAL_TRIALS research · 2025-10-03Clinical Trial Update: Serum Collection Study for Assay Development [Phase 1]
A Phase 1 serum collection study sponsored by GPN Vaccines aims to develop assays for pneumococcal disease and is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-09-02Clinical Trial Update: Phase 2 Trial to Evaluate Safety and Immunogenicity of Inventprise's (IVT) 25-valent Pneumococcal Conjugate Vaccine (IVT PCV-25) in Healthy Infants [Phase 2]
Phase 2 trial by Inventprise evaluating safety and immunogenicity of IVT PCV-25 in healthy infants. The study status is active but not recru…
-
CLINICAL_TRIALS trial_result · 2024-11-12Clinical Trial Update: The Effect of Fractional Doses of Pneumococcal Conjugate Vaccines on Immunogenicity and Carriage in Kenyan Infants [Phase 4]
Phase 4 trial in Kenyan infants assessing whether fractional dosing of pneumococcal conjugate vaccines preserves immunogenicity and reduces …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-07-03Clinical Trial Update: A Phase 3 Study to Evaluate the Immunogenicity and Safety of Walvax's PCV13-TT as Compared to Pfizer's PCV13 [Phase 3]
Phase 3 trial evaluating the immunogenicity and safety of Walvax's PCV13-TT compared with Pfizer's PCV13 (Prevnar 13); study is currently ac…
-
CLINICAL_TRIALS research · 2024-05-21Clinical Trial Update: Evaluation of Vaccination for Streptococcus Pneumoniae in Adults With an Episode of Invasive Pneumococcal Infection.
Clinical trial evaluating pneumococcal vaccination in adults after an episode of invasive pneumococcal disease; currently not yet recruiting…
-
CLINICAL_TRIALS trial_result · 2024-04-16Clinical Trial Update: Safety, Tolerability, and Immunogenicity Study of a 24-Valent Pneumococcal Conjugate Vaccine (VAX-24) in Older Adults [Phase 2]
Phase 2 safety, tolerability, and immunogenicity data for VAX-24 in older adults have been updated with results posted from the completed st…
-
CLINICAL_TRIALS research · 2024-03-04Clinical Trial Update: CIRN Pneumococcal Conjugate Vaccine 1 vs. 2 Dose Priming Study [Phase 2, Phase 3]
Phase 2/Phase 3 trial update evaluating two-dose priming strategies for CIRN Pneumococcal Conjugate Vaccine, completed.
-
CLINICAL_TRIALS trial_result · 2020-10-14Clinical Trial Update: Immunogenicity and Safety Study of the 13-valent Pneumococcal Polysaccharide Conjugate Vaccine in 2-71 Months Old Healthy Infants and Toddlers (the Youngest Could be 6 Weeks Old) [Phase 3]
Phase 3 trial assessing immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in healthy infants and toddlers aged 2-71 mo…
-
CLINICAL_TRIALS trial_result · 2020-09-25Clinical Trial Update: Evaluation of Effectiveness of GSK Biologicals' Pneumococcal Conjugate Vaccine 1024850A Against Invasive Disease [Phase 3]
Phase 3 trial evaluating GSK's pneumococcal conjugate vaccine 1024850A for effectiveness against invasive pneumococcal disease; trial comple…
-
CLINICAL_TRIALS trial_result · 2019-10-30Clinical Trial Update: Safety and Efficacy Study of Investigational Pneumococcal Vaccine in Elderly Population [Phase 2]
Phase 2 clinical trial assessing safety and efficacy of an investigational pneumococcal vaccine in the elderly has completed.
-
CLINICAL_TRIALS research · 2017-03-03Clinical Trial Update: Impact of Introduction of PHiD-CV for Nunavik Children, Quebec, Canada
This clinical trial update examines the impact of introducing the pneumococcal vaccine PHiD-CV (Synflorix) for Nunavik children. It covers o…
-
CLINICAL_TRIALS trial_result · 2016-07-01Clinical Trial Update: 13-valent Pneumococcal Conjugate Vaccine Study in Adults and Children in India [Phase 4]
Phase 4 trial in India evaluating the prevention of pneumonia and invasive pneumococcal disease caused by serotypes included in the 13-valen…
-
CLINICAL_TRIALS trial_result · 2016-07-01Clinical Trial Update: Concomitant Administration of 13-valent Pneumococcal Conjugate Vaccine (13vPnC) With Influenza Vaccine in 23-valent Pneumococcal Polysaccharide (23vPS) Pre-vaccinated Adults. [Phase 4]
Phase 4 trial evaluating concomitant administration of Prevnar 13 with an influenza vaccine in adults previously vaccinated with Pneumovax 2…
-
CLINICAL_TRIALS trial_result · 2016-06-17Clinical Trial Update: Safety Study of Pneumococcal 13-valent Conjugate Vaccine in Healthy People Aged 2 Months and Older [Phase 1]
This is a Phase 1 safety study update for the Pneumococcal 13-valent Conjugate Vaccine in healthy people aged 2 months and older.
-
CLINICAL_TRIALS trial_result · 2015-12-11Clinical Trial Update: Safety and Immunogenicity Study of Prophylactic Streptococcus Pneumoniae Vaccine [Phase 1]
This completed Phase 1 study evaluated the safety and immunogenicity of Genocea Biosciences' prophylactic Streptococcus pneumoniae vaccine. …
-
CLINICAL_TRIALS trial_result · 2015-11-09Clinical Trial Update: An Alternative Booster Vaccine Against Meningitis and Ear Infections [Phase 3]
A Phase 3 trial by the University of Oxford evaluating an alternative booster vaccine against meningitis and ear infections has completed.
-
CLINICAL_TRIALS trial_result · 2015-05-21Clinical Trial Update: Safety and Immunogenicity Study of MenC-TT Vaccine (NeisVac-C) in Toddlers Previously Immunized With PCV7 (Prevenar®) [Phase 3]
Pfizer completed a Phase 3 safety and immunogenicity study of NeisVac-C (meningococcal serogroup C conjugate vaccine) in toddlers previously…
-
CLINICAL_TRIALS trial_result · 2015-01-19Clinical Trial Update: Impact of PCV on Disease and Colonization Among Native American Communities
Completed trial assessing the impact of pneumococcal conjugate vaccination on pneumococcal nasopharyngeal colonization and invasive pneumoco…
-
CLINICAL_TRIALS trial_result · 2014-06-05Clinical Trial Update: Phase I Safety Trial of Streptococcus Pneumoniae Whole Cell Vaccine (SPWCV) + Alum in Healthy Adults [Phase 1]
Phase I safety study of a Streptococcus pneumoniae whole-cell vaccine with alum adjuvant (SPWCV+Al) in healthy adults; results posted.
-
CLINICAL_TRIALS trial_result · 2012-11-29Clinical Trial Update: Study Evaluating Prevenar in the Prevention of Invasive Pneumococcal Disease (IPD) in the Paediatric Population in Spain.
Pfizer's Prevenar vaccine trial in children in Spain to prevent invasive pneumococcal disease has completed.
-
CLINICAL_TRIALS trial_result · 2012-08-15Clinical Trial Update: Study to Evaluate a 13-valent Pneumococcal Conjugate Vaccine in Infants [Phase 3]
This entry reports the completion of a Phase 3 study evaluating a 13-valent pneumococcal conjugate vaccine in infants and the posting of res…
-
CLINICAL_TRIALS trial_result · 2011-01-05Clinical Trial Update: Immune Response In Children Revaccinated With Pneumococcal Conjugate Vaccine [Phase 3]
Phase 3 trial update on immune response in children revaccinated with pneumococcal conjugate vaccine; study completed with results posted in…
-
CLINICAL_TRIALS trial_result · 2010-10-15Clinical Trial Update: Study Evaluating 13-valent Pneumococcal Conjugate Vaccine in Healthy Infants in Brazil [Phase 3]
Phase 3 study evaluating the 13-valent pneumococcal conjugate vaccine in healthy Brazilian infants has completed, with results posted in 201…